Qlaris Bio has a total of 11 patents globally, out of which no patents have been granted. Of these 11 patents, more than 81% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Qlaris Bio.
Qlaris Bio was founded in the year 2019. The Company is a clinical stage biotechnology company founded on a relentless commitment to develop innovative first-in-class therapies that can make a truly impactful change for patients suffering from serious and debilitating ophthalmic diseases.
Do read about some of the most popular patents of Qlaris Bio which have been covered by us in this article and also you can find Qlaris Bio patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Qlaris Bio patent portfolio.
How many patents does the founder and the CEO of Qlaris Bio have?
The founder Barbara Wirostko has 2 patents and CEO Thurein Htoo (also founder) has 0 patent.
How many patents does Qlaris Bio have?
Qlaris Bio has a total of 11 patents globally. These patents belong to 3 unique patent families. Out of 11 patents, 9 patents are active.
How Many Patents did Qlaris Bio File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Qlaris Bio Applications Filed | Qlaris Bio Patents Granted |
| 2022 | 3 | – |
| 2021 | 4 | – |
| 2020 | 4 | – |
How many Qlaris Bio patents are Alive/Dead?
How Many Patents did Qlaris Bio File in Different Countries?
Countries in which Qlaris Bio Filed Patents
| Country | Patents |
| Australia | 2 |
| United States Of America | 2 |
| Canada | 2 |
| Europe | 2 |
Where are Research Centres of Qlaris Bio Patents Located?
The Research Centre for all the Qlaris Bio patents is the United States of America.
List of Qlaris Bio Patents
| Olaris Bio Patents | Title |
| US20220387457A1 | Methods And Compositions For Cromakalim Prodrug Therapy |
| US20220324890A1 | Controlled-Delivery Cromakalim Prodrugs |
| EP4100003A1 | Improved Methods And Compositions For Cromakalim Prodrug Therapy |
| EP4072543A1 | Controlled-Delivery Cromakalim Prodrugs |
| WO2023018958A1 | Compositions And Methods For Extended Release Cromakalim Therapy |
| AU2021215932A1 | Improved Methods And Compositions For Cromakalim Prodrug Therapy |
| AU2020403144A1 | Controlled-Delivery Cromakalim Prodrugs |
| CA3166579A1 | Improved Methods And Compositions For Cromakalim Prodrug Therapy |
| CA3159771A1 | Controlled-Delivery Cromakalim Prodrugs |
| WO2021158992A1 | Improved Methods And Compositions For Cromakalim Prodrug Therapy |
| WO2021119503A1 | Controlled-Delivery Cromakalim Prodrugs |
What are Qlaris Bio’ key innovation segments?
What Technologies are Covered by Qlaris Bio?
The chart below distributes patents filed by Qlaris Bio